Optos Stock Rating Lowered by N+1 Singer (OPTS)

Optos (LON: OPTS) was downgraded by equities researchers at N+1 Singer to a “sell” rating in a report issued on Thursday. They currently have a $2.60 (172 GBX) target price on the stock.

Optos (LON: OPTS) traded down 2.41% during mid-day trading on Thursday, hitting GBX 162.00. Optos has a 52-week low of GBX 160.00 and a 52-week high of GBX 280.00. The stock’s 50-day moving average is currently GBX 190.0. The company’s market cap is £116.0 million.

Other equities research analysts have also recently issued reports about the stock. Analysts at Investec reiterated a “sell” rating on shares of Optos in a research note to investors on Thursday. They now have a $2.37 price target on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Optos in a research note to investors on Wednesday. They now have a $4.23 price target on the stock. Finally, analysts at Canaccord Genuity cut their price target on shares of Optos from $4.73 to $4.71 in a research note to investors on Wednesday. They now have a “buy” rating on the stock.

Three equities research analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $3.61 (239 GBX).

Optos plc is a retinal imaging company. The Company’s medical devices produce ultra-widefield, high resolution digital images of approximately 82% of the retina in a single capture.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.